Home Medicine Phenotypic variation among four members in a family with DAX1 deficiency
Article
Licensed
Unlicensed Requires Authentication

Phenotypic variation among four members in a family with DAX1 deficiency

  • Yuko Seki EMAIL logo , Haruna Kakimoto , Izumi Tamada , Shozo Oku , Satoshi Morita , Minako Tokunaga , Michiyo Mizota , Naoko Amano , Noboru Uchida , Tomonobu Hasegawa and Yasuhiro Okamoto
Published/Copyright: July 29, 2025

Abstract

Objectives

To describe four members of a family with DAX1 deficiency caused by a novel NR0B1variant.

Case presentation

All family members carried a novel hemizygous NR0B1 variant, p.Gln318Alafs*71. The elder brother, aged 13 years, developed an adrenal crisis at the age of 3 years. The third brother, aged 4 years, showed a relatively low cortisol response to the short Synacthen test, but exhibited no clinical signs of adrenal insufficiency. The youngest brother developed an adrenal crisis at the age of 16 days. Additionally, their 14-year-old cousin was diagnosed with DAX1 deficiency based on skin pigmentation and family history.

Conclusions

Despite carrying the same NR0B1 variant, the initial symptoms and age of adrenal insufficiency onset varied among the four members of this family. Male members with a family history of DAX1 deficiency should be confirmed genetically as possible.


Corresponding author: Yuko Seki, MD, Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Science, Kagoshima, Japan, E-mail:

  1. Research ethics: Not applicable.

  2. Informed consent: Informed consent was obtained from all individuals included in this study, or their legal guardians or wards.

  3. Author contributions: Yuko Seki, Naoko Amano, and Yasuhiro Okamoto wrote the paper; Haruna Kakimoto, Michiyo Mizota, Minako Tokunaga, Satoshi Morita, Izumi Tamada, and Shozo Oku took care of the patients; Naoko Amano, Noboru Uchida, and Tomonobu Hasegawa performed the genetic analysis. All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Use of Large Language Models, AI and Machine Learning Tools: None declared.

  5. Conflict of interest: Tomonobu Hasegawa has the following financial relationships to disclose: Research funding from Novo Nordisk Pharma Ltd. and JCR Pharmaceuticals Co.,Ltd. The other authors state no conflict of interest.

  6. Research funding: None declared.

  7. Data availability: Not applicable.

References

1. Hay, ID, Smail, PJ, Forsyth, CC. Familial cytomegalic adrenocortical hypoplasia: an X-linked syndrome of pubertal failure. Arch Dis Child 1981;56:715–21. https://doi.org/10.1136/adc.56.9.715.Search in Google Scholar PubMed PubMed Central

2. Reutens, AT, Achermann, JC, Ito, M, Ito, M, Gu, WX, Habiby, RL, et al.. Clinical and functional effects of mutations in the DAX-1 gene in patients with adrenal hypoplasia congenita. J Clin Endocrinol Metab 1999;84:504–11. https://doi.org/10.1210/jcem.84.2.5468.Search in Google Scholar PubMed

3. Hasegawa, Y, Takahashi, Y, Kezuka, Y, Obara, W, Kato, Y, Tamura, S, et al.. Identification and analysis of a novel NR0B1 mutation in late-onset adrenal hypoplasia congenita and hypogonadism. J Endocr Soc 2021;5:bvaa176. https://doi.org/10.1210/jendso/bvaa176.Search in Google Scholar PubMed PubMed Central

4. Kyriakakis, N, Shonibare, T, Kyaw-Tun, J, Lynch, J, Lagos, CF, Achermann, JC, et al.. Late-onset X-linked adrenal hypoplasia (DAX-1, NR0B1): two new adult-onset cases from a single center. Pituitary 2017;20:585–93. https://doi.org/10.1007/s11102-017-0822-x.Search in Google Scholar PubMed PubMed Central

5. Wu, SM, Gao, JZ, He, B, Long, WJ, Luo, XP, Chen, L, et al.. A novel NR0B1 gene mutation causes different phenotypes in two male patients with congenital adrenal hypoplasia. Curr Med Sci 2020;40:172–7. https://doi.org/10.1007/s11596-020-2161-9.Search in Google Scholar PubMed

6. Lu, Y, Liu, Y, Liao, S, Tu, W, Shen, Y, Yan, Y, et al.. Epigenetic modifications promote the expression of the orphan nuclear receptor NR0B1 in human lung adenocarcinoma cells. Oncotarget 2016;7:43162–76. https://doi.org/10.18632/oncotarget.9012.Search in Google Scholar PubMed PubMed Central

7. Raffin-Sanson, ML, Oudet, B, Salenave, S, Brailly-Tabard, S, Pehuet, M, Christin-Maitre, S, et al.. A man with a DAX1/NR0B1 mutation, normal puberty, and an intact hypothalamic-pituitary-gonadal axis but deteriorating oligospermia during long-term follow-up. Eur J Endocrinol 2013;168:K45–50. https://doi.org/10.1530/eje-12-1055.Search in Google Scholar

8. Achermann, JC, Meeks, JJ, Jameson, JL. Phenotypic spectrum of mutations in DAX-1 and SF-1. Mol Cell Endocrinol 2001;185:17–25. https://doi.org/10.1016/s0303-7207-01-00619-0.Search in Google Scholar

9. Kaiserman, KB, Nakamoto, JM, Geffner, ME, McCabe, ER. Minipuberty of infancy and adolescent pubertal function in adrenal hypoplasia congenita. J Pediatr 1998;133:300–2. https://doi.org/10.1016/s0022-3476-98-70242-2.Search in Google Scholar

10. Takahashi, T, Shoji, Y, Shoji, Y, Haraguchi, N, Takahashi, I, Takada, G, et al.. Active hypothalamic-pituitary-gonadal axis in an infant with X-linked adrenal hypoplasia congenita. J Pediatr 1997;130:485–8. https://doi.org/10.1016/s0022-3476-97-70217-8.Search in Google Scholar

Received: 2025-02-03
Accepted: 2025-07-16
Published Online: 2025-07-29
Published in Print: 2025-11-25

© 2025 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Original Articles
  3. Spatiotemporal associations between incidence of type 1 diabetes and COVID-19 vaccination rates in children in Germany – a population-based ecological study
  4. Continuous glucose monitoring evidence of celiac disease in type 1 diabetes
  5. Impact of race and delayed adoption of diabetes technology on glycemia and partial remission in type 1 diabetes
  6. Immunogenetic profiling of type 1 diabetes in Jordan: a case-control study on HLA-associated risk and protection
  7. Annual case counts and clinical characteristics of pediatric and adolescent patients with diabetes in Kenyatta National Hospital, Nairobi, Kenya. A 14 year retrospective study
  8. Real-world effectiveness of sodium glucose transporter 2 inhibitors among youth with type 2 diabetes
  9. Investigation of the association between nitric oxide synthase gene variants and NAFLD in adolescents with obesity
  10. Cardiometabolic outcomes in girls with premature adrenarche: a longitudinal analysis of typical vs. exaggerated presentations
  11. A disease that is difficult to predict: regional distribution and phenotypic, histopathological and genetic findings in McArdle disease
  12. Causal analysis of uterine artery pulsatility index-related proteins and the risk of precocious puberty in girls: a Mendelian randomization study
  13. Case Reports
  14. Understanding rickets in osteopetrosis via a case: mechanisms and treatment implications
  15. A case of JAGN1 mutation presenting with atypical diabetes and immunodeficiency
  16. Compound heterozygous ROBO1 gene variants in a neonate with congenital hypopituitarism, dysmorphic features and midline abnormalities: a case report and review of the literature
  17. Phenotypic variation among four members in a family with DAX1 deficiency
  18. MMP13-related metaphyseal dysplasia: a differential diagnosis of rickets
  19. Congress Abstracts
  20. JA-PED | Annual Meeting of the German Society for Pediatric and Adolescent Endocrinology and Diabetology (DGPAED e. V.)
Downloaded on 19.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2025-0063/html
Scroll to top button